EICHOR
● Active Not Recruiting
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2 · Sponsor: Novo Nordisk A/S
About this study
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medicine). The study will be performed in people with type 2 diabetes. Participants will either get semaglutide or placebo in addition to their diabetes medicines - which treatment the participant gets is decided by chance. Participants will inject the study medicine using a pen-injector. The medicine must be injected in a skin fold in the stomach, thigh or upper arm once a week. The study will last for 5 years.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (229)
| Synexus Rsch /Cnt Phnx Med C | Phoenix, Arizona, United States | — |
| Del Sol Research Management, LLC | Tucson, Arizona, United States | — |
| South Arizona VA Healthcare System | Tucson, Arizona, United States | — |
| Synexus Cln Rsrch Inc - Orange Gro FP | Tucson, Arizona, United States | — |
| Southern California Res Ctr | Coronado, California, United States | — |
| FDRC | Costa Mesa, California, United States | — |
| Advanced Investigative Medicine, Inc. | Hawthorne, California, United States | — |
| Diabetes/Lipid Mgmt & Res Ctr | Huntington Beach, California, United States | — |
| Scripps Whittier Diabetes Inst | La Jolla, California, United States | — |
| Torrance Clin Res Inst, Inc. | Lomita, California, United States | — |
| Angel City Research, Inc. | Los Angeles, California, United States | — |
| Downtown LA Res Ctr. Inc. | Los Angeles, California, United States | — |
+ 217 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03811561